NCT06365255Completed
National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 17 Apr 2024
Brief summary (registry, in English)
The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres. In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1344 (actual)
- First submitted
- 8 Apr 2024
- Start date
- 17 Jan 2023
- Primary completion date
- 28 Feb 2024
- Lead sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
- Diseases
- Type 1 diabetes
- NCT number
- NCT06365255
What you commit to
- Study type: Observational
- Participants enrolled: 1344
- From 17 Jan 2023 to the primary completion date, 28 Feb 2024
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with type 2 diabetes
Other
- Patient who has declared his opposition using the electronic non-opposition form
Who the study is looking for
- Patients with type 1 diabetes;
- Do not have a psychiatric pathology;
- At least 18 years old;
- Affiliated to the Social Security;
- Having read the non-opposition form and not objecting to it.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Angers University Hospital Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| Avignon Hospital Coordinator of this site? Confirm its status | Avignon | France | Unknown status |
| St André Hospital Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
| Brest University Hospital Coordinator of this site? Confirm its status | Brest | France | Unknown status |
| Dijon University Hospital Coordinator of this site? Confirm its status | Dijon | France | Unknown status |
| CERITD Coordinator of this site? Confirm its status | Évry | France | Unknown status |
| Grenoble University Hospital Coordinator of this site? Confirm its status | Grenoble | France | Unknown status |
| Lille University Hospital Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| APHM- La Conception Hospital Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
| Private practice in endocrinology and metabolic diseases Coordinator of this site? Confirm its status | Mérignac | France | Unknown status |
| Srasbourg University Hospital Coordinator of this site? Confirm its status | Strasbourg | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.